Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe
Post date: 2020-01-15 20:00:09
Views: 151
Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding. Leading the round is MTIP, with participation by new investor Earlybird, and existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech. Oviva says the new capital will be used
Please click Here to read the full story.
 
Other Top and Latest Questions:
Can a category be hidden from search results and not appear on the first page?
Senate passes reauthorization of a key U.S. surveillance program after midnight deadline
Korean Cooking Show
DIY Dishwasher Installation?
strap
What should I make with these chicken thighs given the following...
Why the oil market shrugged as Iran and Israel appeared on the brink of war this week
Oasis launches a campaign at Kao Corp, but this battle is likely to be a difficult one
Buy these five stocks ahead of earnings before it's too late, Bank of America says
Tesla recalls Cybertruck over 'trapped pedal' issue seen in owner's viral TikTok video